Observational Study on Cannabis Use and Immunotherapy in Cancer
This study, called IMPACT-C, is looking at how people with cancer who are receiving immunotherapy (treatments that help your body's immune system fight cancer) manage their symptoms. Researchers want to understand how different methods, including cannabis, affect symptoms like pain, sleep, and anxiety. You might be able to join if you are at least 21 years old, have cancer, are planning to use or are already using immunotherapy, and experience pain. This study will help us learn more about managing cancer symptoms and improving patient care. The study is currently unclear on its recruitment status and aims to enroll 450 participants.
- Study design
- This is an observational study, meaning researchers will watch and collect information without giving specific treatments. It aims to enroll 450 participants.
- What's involved
- You would complete online surveys and short daily assessments for 7 days at 0, 1, 2, 4, 6, 9, and 12 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- You will be followed for 12 months after starting the study.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer
At a glance
Conditions
Where it's being run
2 sites across 2 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Patient Reported Outcomes Measurement Information System: Pain interference0,1,2,4,6,9 and 12 months
Pain interference with daily life and enjoyment on a 5 item scale of not at all to very much. Higher score indicates worse outcome.
- Patient Reported Outcomes Measurement Information System: Sleep0,1,2,4,6,9 and 12 months
PROMISE sleep disturbance on a 5 item scale of not at all to very much. Higher score indicates worse outcome.
- Patient Reported Outcomes Measurement Information System:Anxiety0,1,2,4,6,9 and 12 months
Anxiety on a 5 item scale of never to always. Higher score indicates worse outcome. Higher score indicates worse outcome.
- Adverse reaction of Cannabis0,1,2,4,6,9 and 12 months
Adverse reaction to Cannabis Scale of present side effects and 5 item scale of how distressing the symptoms were experienced. Higher score indicates worse outcome.
- Cannabis Use Disorder Identification Test0,1,2,4,6,9 and 12 months
Cannabis Use Disorder Identification Test (CUDIT), the usage of cannabis and 5 item scale of never to daily or almost daily. Higher score indicates worse outcome.
- Patient Reported Outcomes Measurement Information System: Depression0,1,2,4,6,9 and 12 months
Emotional Distress-Depression on a 5 item scale of never to always, level of sexual activity, emotional well-being, functional well-being and additional concerns on a 5 item scale not at all to very much. Higher score indicates worse outcome.
- Patient Reported Outcomes Measurement Information System: Cognitive Function0,1,2,4,6,9 and 12 months
Cognitive Function-Abilities on a 5 item scal not at all to very much. Higher score indicates better outcome.
- Patient Reported Outcomes Measurement Information System: Fatigue0,1,2,4,6,9 and 12 months
Level of fatigue on a 5 item scale of never to always. Higher score indicates worse outcome.